Biotech Advantage SRL
Biotech Advantage reported total assets of 470,539 € at the end of the 2026 financial year (annual accounts filed with the NBB on 30 Oct 2026).
The score of Biotech Advantage shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2026
Change 2023 → 2026: Equity +318 % Total assets +211 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Biotech Advantage's annual accounts
| 2026 | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
| Net result | 174,330 € | |||
| Equity | 400,304 € | |||
| Cash | 205,198 € | |||
| EBITDA | 227,071 € | |||
| Total assets | 470,539 € |
Filed annual accounts
- Year ended 31 Mar 2026filed on 30 Oct 2026
- Year ended 31 Mar 2025filed on 28 Oct 2025
- Year ended 31 Mar 2024filed on 16 Oct 2024
- Year ended 31 Mar 2023filed on 30 Oct 2023
Biotech Advantage's financial analysis
- Solvency85.1%sector median: 50.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Biotech Advantage
Biotech Advantage's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0787.767.583
- VAT number
- BE0787767583
- Peppol
- Registered · 0208:0787767583 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 28 Jun 2022
- Registered office
- 1380 Lasne
- Latest accounts
- 2026 · filed on 30 Oct 2026
- Activity
- Business and other management consultancy activities (NACE 70200)
Biotech Advantage (SRL) has been based in Lasne since 2022, active in: business and other management consultancy activities. For 2026, it reports a net profit of 174,330 € and equity of 400,304 €; its revenue is not published. Its solvency stands at 85.1%, above the median of its sector (50.1%).
Companies similar to Biotech Advantage
Companies in the same business, of comparable size and area, outside its group.
- GMN Management Business and other management consultancy activities Antwerp · balance sheet 449,850 €
- Delvedo Business and other management consultancy activities Dendermonde · balance sheet 440,691 €
- Judge Business and other management consultancy activities Tienen · balance sheet 485,361 €
- Laurus M&C Business and other management consultancy activities Hasselt · balance sheet 420,004 €
- OUT-CO Business and other management consultancy activities Antwerp · balance sheet 538,131 €
- Loggix Business and other management consultancy activities Antwerp · balance sheet 537,666 €
- FVC Management Business and other management consultancy activities Ostend · balance sheet 404,818 €
- Fennec Mgmt Business and other management consultancy activities Antwerp · balance sheet 397,528 €
Frequently asked questions about Biotech Advantage
What is the revenue of Biotech Advantage?
Biotech Advantage files its accounts in a format where revenue is optional: it is not published for 2026.
What is the VAT number of Biotech Advantage?
In Belgium, the VAT number is the company number prefixed with BE: BE0787767583 for Biotech Advantage, if the company is VAT-registered. Its company number (CBE) is 0787.767.583.
Where is the registered office of Biotech Advantage?
According to the CBE register, the registered office of Biotech Advantage is in 1380 Lasne.
What is the equity of Biotech Advantage?
At the close of the 2026 financial year, the equity of Biotech Advantage amounts to 400,304 €, a solvency of 85.1% of total assets.
Who manages Biotech Advantage?
The register lists 1 active mandates at Biotech Advantage. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Biotech Advantage
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →